SBI Holdings, Inc.

8473.T · Tokyo Stock Exchange · JPY

2.884,50JPY

+31,50 (+1,10 %)Stand 11. Nov., 3:55

Vortag 2.853,00

Kennzahlen

Eröffnung
2.853,00
Vortag
2.853,00
Tagesspanne
2.850,00 – 2.893,50
52 Wochen
2.631,00 – 3.866,00
Volumen
1,6 Mio.
Ø Volumen
4,14 Mio.
Börsenwert
1,86 Bio. ¥
KGV
3,8
Gewinn je Aktie (TTM)
729,55
Dividendenrendite
3,6 %
Beta
0,5
Nächste Zahlen
10. Feb. 2027

Finanzen

JPYFY 2026FY 2025FY 2024FY 2023FY 2022
Umsatz1,9 Bio.1,35 Bio.1,19 Bio.911,97 Mrd.650,48 Mrd.
Herstellungskosten771,84 Mrd.384,87 Mrd.359,59 Mrd.279,06 Mrd.276,52 Mrd.
Bruttogewinn1,12 Bio.968,76 Mrd.829,91 Mrd.632,92 Mrd.373,96 Mrd.
Forschung und Entwicklung00000
Vertrieb und Verwaltung00000
Operatives Ergebnis516,59 Mrd.607,05 Mrd.413,98 Mrd.295,35 Mrd.204,72 Mrd.
EBITDA584,32 Mrd.581,39 Mrd.404,96 Mrd.278,63 Mrd.487 Mrd.
Nettogewinn427,58 Mrd.162,12 Mrd.87,24 Mrd.35,45 Mrd.366,85 Mrd.
Gewinn je Aktie (verwässert)624,54256,34142,8059,17642,95

Bewertung

Letzte 12 Monate

KGV
3,8
Kurs-Umsatz-Verhältnis
0,9
Kurs-Buchwert-Verhältnis
1,0
PEG
0,1
Bruttomarge
70,8 %
Operative Marge
39,1 %
Nettomarge
24,1 %
Verschuldungsgrad
4,0
EV/EBITDA
3,9
Eigenkapitalrendite
26,8 %
Kapitalrendite (ROIC)
1,6 %
Free-Cashflow-Rendite
41,1 %
FY 2026FY 2025FY 2024FY 2023FY 2022
Bruttomarge59,3 %71,6 %69,8 %69,4 %57,5 %
Operative Marge27,2 %44,8 %34,8 %32,4 %31,5 %
Nettomarge22,5 %12,0 %7,3 %3,9 %56,4 %
KGV4,37,412,019,62,1
Kurs-Umsatz-Verhältnis1,00,90,90,81,2
Kurs-Buchwert-Verhältnis1,01,00,80,70,8
Verschuldungsgrad3,96,14,85,13,7
Liquidität 3. Grades9,91,20,81,21,4
Dividendenrendite3,0 %4,0 %3,9 %5,4 %4,2 %
Unternehmenswert2,44 Bio.3,44 Bio.2,47 Bio.2,66 Bio.1,68 Bio.
EV/EBITDA4,25,96,19,63,4
Eigenkapitalrendite23,8 %12,9 %6,9 %3,5 %39,7 %
Kapitalrendite (ROIC)1,1 %4,0 %4,0 %2,0 %1,9 %
Free-Cashflow-Rendite0,0 %138,4 %135,8 %145,5 %−19,7 %

Wachstum

FY 2026FY 2025FY 2024FY 2023FY 2022
Umsatz+40,1 %+13,8 %+30,4 %+40,2 %+24,6 %
Bruttogewinn+16,1 %+16,7 %+31,1 %+69,2 %+11,0 %
Operatives Ergebnis−14,9 %+46,6 %+40,2 %+44,3 %+18,8 %
Nettogewinn+163,7 %+85,8 %+146,1 %−90,3 %+352,4 %
Gewinn je Aktie+143,6 %+79,5 %+141,3 %−90,8 %+333,1 %
Freier Cashflow−100,0 %+17,2 %+40,7 %+776,7 %−218,2 %
Dividende je Aktie+8,6 %+7,6 %+4,6 %+9,3 %+33,0 %

Analysten

Einstufungen

Gerade nicht verfügbar.

Kursziel

Gerade nicht verfügbar.

Schätzungen

FY 2027FY 2028FY 2029
Umsatz (Ø)1,65 Bio.1,64 Bio.1,71 Bio.
Umsatz (Tief – Hoch)1,57 Bio. – 1,73 Bio.1,51 Bio. – 1,77 Bio.1,53 Bio. – 1,92 Bio.
Gewinn je Aktie (Ø)466,39340,38356,28
Gewinn je Aktie (Tief – Hoch)440,79 – 482,29238,06 – 439,58237,96 – 468,40
Analysten265

Quartalszahlen

Nächste Zahlen: 10. Feb. 2027
Nov. 2026Juli 2026Mai 2026Feb. 2026Okt. 2025Juli 2025Mai 2025Feb. 2025
Gewinn je Aktie · Erwartet90,11104,45101,36170,1549,2271,6451,85117,63
Gewinn je Aktie · Tatsächlich127,63229,07120,28282,77129,43139,60195,3793,29
Abweichung+41,64 %+119,31 %+18,67 %+66,19 %+162,96 %+94,86 %+276,80 %−20,69 %
Umsatz · Tatsächlich487,57 Mrd.571,01 Mrd.406,95 Mrd.587,1 Mrd.478,83 Mrd.443,19 Mrd.430,34 Mrd.337,36 Mrd.

Dividenden und Splits

Ex-TagZahltagBetrag
30. März 202730. März 202780,00
29. Sept. 202614. Dez. 202630,00
30. März 20268. Juni 202675,00
29. Sept. 202515. Dez. 202540,00
28. März 20259. Juni 2025140,00
27. Sept. 202416. Dez. 202430,00
28. März 20247. Juni 2024130,00
28. Sept. 202318. Dez. 202330,00
30. März 20239. Juni 2023120,00
29. Sept. 202219. Dez. 202230,00
30. März 202230. Juni 2022120,00
29. Sept. 202113. Dez. 202130,00

Aktiensplits

  • 27. Nov. 20252:1
  • 26. Sept. 201210:1
  • 6. Aug. 20043:1
  • 25. Nov. 20033:1
  • 25. Sept. 20013:1

Eigentümer

Institutionen

Gerade nicht verfügbar.

Insider-Geschäfte

–

Vergleichbare Unternehmen

Über das Unternehmen

SBI Holdings, Inc. is a Japanese conglomerate primarily engaged in online financial services and strategic investments, both domestically and internationally. Its operations are structured around three key pillars: Financial Services, Asset Management, and the Biotechnology, Healthcare, and Medical Informatics sectors. The company provides a comprehensive suite of financial products, including online brokerage, investment banking, and internet banking facilities. It offers various insurance solutions such as automobile, health (cancer), property (fire, earthquake), and life coverage, alongside short-term insurance. Further financial offerings encompass foreign exchange (FX) margin trading, online securities, and services related to digital asset exchange and transactions. SBI also manages defined-contribution pension schemes, provides leasing and lending services, and operates a proprietary trading system. Its involvement extends to e-commerce settlement processing, remittance services, and essential back-office support. Beyond traditional banking, SBI is active in private equity and venture capital fund management, offers mergers and acquisitions (M&A) advisory, and runs savings and commercial banking operations. It provides investment advisory and management services, alongside rating information services. The firm also deals with real estate-secured loans and offers rent guarantees for residential properties. In the biotechnology and healthcare domain, SBI conducts research, manufactures, and distributes pharmaceutical products, health supplements, and cosmetics. It develops, produces, sells, and maintains integrated medical information systems. Furthermore, it's involved in the research and development of advanced antibody and nucleic acid drugs targeting cancer and immunological conditions. The company's diverse portfolio includes operating a fund-raising platform, serving as a crypto-asset broker, and developing, manufacturing, and selling crypto-asset mining systems. It also develops and manages cybersecurity systems, provides blockchain platforms, invests in real estate, and engages in used car exports. Additionally, SBI offers healthcare services, participates in revitalization projects, mines digital assets, and is involved in e-sports and renewable energy initiatives. Established in 1999, the company was initially known as Softbank Investment Corporation before adopting its current name, SBI Holdings, Inc., in July 2005. Its headquarters are located in Tokyo, Japan.

Führung

  • Yoshitaka KitaoChairman, President, CEO & Representative Director
  • Masato TakamuraSenior EVice President, Chief Operating Officer, Senior Head of Financial Services Business & Representative Director
  • Tomoya AsakuraSenior Executive Vice President & Representative Director
  • Hideyuki KatsuchiExecutive Officer of Accounting & Finance
  • Masashi OkuyamaExecutive Officer, GM of the Legal & Compliance and Director
  • Motoaki ShiinoGM of Corporate Communication Department & Director
CEO
Yoshitaka Kitao
Mitarbeitende
18.669
Hauptsitz
Tokyo, TY, JP
Sektor
Financial Services
Branche
Financial - Conglomerates
Börsengang
4. Jan. 2001

Nachrichten

Gerade keine Nachrichten zu diesem Unternehmen.

Kurse mindestens 15 Minuten verzögert. Daten: Financial Modeling Prep. Keine Anlageberatung.